These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 987254)

  • 1. Time-course changes in blood pressure, urinary excretion of norepinephrine and dopamine after administration of fusaric acid in a single dose in elderly hypertensive patients.
    Terasawa F; Hidaka H
    Jpn Circ J; 1976 Jul; 40(7):785-91. PubMed ID: 987254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary norepinephrine excretion in elderly hypertensive patients during administration of fusaric acid.
    Terasawa F; Ying LH; Suzuki T; Hidaka H
    Jpn Circ J; 1976 Sep; 40(9):1033-7. PubMed ID: 994315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term hemodynamic effect of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Suzuki T
    Jpn Circ J; 1976 Sep; 40(9):1025-31. PubMed ID: 994314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypotensive effect of fusaric acid: the results of long-term administration of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Kameyama M
    Jpn Circ J; 1976 Sep; 40(9):1017-23. PubMed ID: 994313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of fusaric acid on urinary excretion of catecholamines: a clinical study with particular emphasis on the characteristics of its time-course change.
    Ozawa N
    Jpn Circ J; 1972 Nov; 36(11):1205-21. PubMed ID: 4678992
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of fusaric acid calcium on catecholamine metabolism and its clinical effects on essential hypertension].
    Ozawa M; Nakajima Y; Suzuki K; Sato T; Takahashi E
    Horumon To Rinsho; 1976 Jan; 24(1):79-86. PubMed ID: 942902
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive effect of trifluoropentoxypicolinic acid: a pharmacokinetic study].
    Horisaka K; Masuda S
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):301-7. PubMed ID: 6745810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man.
    Goodwin FK; Sack RL
    J Psychiatr Res; 1974; 11():211-7. PubMed ID: 4618285
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of elevated serum TSH levels in hypothyroidism by fusaric acid.
    Yoshimura M; Hachiya T; Ochi Y; Nagasaka A; Takeda A
    J Clin Endocrinol Metab; 1977 Jul; 45(1):95-8. PubMed ID: 406275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind placebo-controlled trial of terazosin effect on blood pressure and urinary output of dopamine in hypertensive patients.
    Romero E; Angeli M; Velasco M; Azar E; Bueno O; Lema G; Morales N; Nuchi Y; Rasines C; Wagner A
    J Clin Pharmacol; 1992 Sep; 32(9):816-21. PubMed ID: 1358922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachycardia in spontaneously hypertensive and normotensive rats after fusaric acid and bupicamide.
    Antonaccio MJ; Coté D; Cavaliere T
    Clin Exp Pharmacol Physiol; 1976; 3(3):199-206. PubMed ID: 975616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo release of adrenal catecholamines in rats by fusaric acid.
    Racz K; Kuchel O; Buu NT
    Eur J Pharmacol; 1985 Feb; 109(1):1-7. PubMed ID: 3996464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fusaric acid on tardive dyskinesia and mental state in psychogeriatric patients. A pilot study.
    Viukari M; Linnoila M
    Acta Psychiatr Scand; 1977 Jul; 56(1):57-61. PubMed ID: 331875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variations of urinary dopamine, norepinephrine, epinephrine and sodium in normotensive and hypertensive subjects.
    Kawano Y; Kawasaki T; Kawazoe N; Abe I; Uezono K; Ueno M; Fukiyama K; Omae T
    Nephron; 1990; 55(3):277-82. PubMed ID: 2370928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of pheochromocytoma with fusaric acid].
    Shimpo S; Sakata K; Kawashimo K; Kanagi R; Omori Y
    Horumon To Rinsho; 1976 Jun; 24(6):571-6. PubMed ID: 986906
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.